Chiome Bioscience Inc. (TYO:4583)
Japan · Delayed Price · Currency is JPY 133.00
-5.00 (-3.62%)
Sep 10, 2025, 3:30 PM JST
Chiome Bioscience Market Cap
Chiome Bioscience has a market cap or net worth of 9.05 billion as of September 10, 2025. Its market cap has increased by 41.18% in one year.
Market Cap
9.05B
Enterprise Value
7.84B
Revenue
768.88M
Ranking
n/a
PE Ratio
n/a
Stock Price
133.00
Market Cap Chart
Since December 20, 2011, Chiome Bioscience's market cap has increased from 470.00M to 9.05B, an increase of 1,825.43%. That is a compound annual growth rate of 24.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 9.39B | -46.54% |
| Dec 30, 2024 | 17.56B | 149.35% |
| Dec 29, 2023 | 7.04B | -18.27% |
| Dec 30, 2022 | 8.62B | 9.67% |
| Dec 30, 2021 | 7.86B | 6.96% |
| Dec 30, 2020 | 7.35B | 9.29% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Chugai Pharmaceutical | 10.99T |
| Takeda Pharmaceutical Company | 7,263.27B |
| HOYA Corporation | 7,104.51B |
| Daiichi Sankyo Company | 6,855.89B |
| Otsuka Holdings | 4,476.97B |
| Terumo | 3,919.95B |
| Astellas Pharma | 3,086.49B |
| Shionogi & | 2,292.13B |